Hospitals Sue HHS Over 340B Pilot Program Changes
Hospitals challenge HHS's 340B pilot shifting drug discounts to a rebate system, citing financial risks and regulatory concerns.
Deadline Looms for ACA Premium Tax Credit Renewal Affecting Iowa Market
Federal lawmakers must act by December on ACA premium tax credits that have reduced health insurance costs in Iowa. Without renewal, premiums could rise substantially for those under 400% of poverty.
Congress Focuses on ACA Subsidies and Medicare Hospital Care at Home Extensions
Congress returns to debate the future of enhanced Affordable Care Act subsidies and extends Medicare Hospital Care at Home program, with key health care hearings scheduled this week.
U.S. Prospective MFN Pricing Could Balance Drug Costs and Innovation
Explore how the U.S. prospective most-favored-nation (MFN) pricing strategy aims to lower drug prices while preserving pharmaceutical innovation and encouraging fair global contributions to R&D funding.
CMS Proposes 2027 Medicare Advantage Rule; Drug Price Negotiations Advance
Summary of recent CMS proposals affecting 2027 Medicare Advantage and Part D, plus updates on Medicare drug price negotiations impacting federal health programs.
Higher Quality and Lower Utilization in At-Risk Medicare Advantage for Dual-Eligible Beneficiaries
Analysis reveals at-risk Medicare Advantage models deliver better quality and lower utilization for dual-eligible beneficiaries versus traditional and fee-for-service Medicare, supporting CMS care accountability goals.
Florida Faces Critical ACA Subsidy Deadline as Obamacare Popularity Grows
Florida's large ACA marketplace faces rising premiums as enhanced Obamacare subsidies expire in 2025, impacting millions of enrollees and health insurers.
U.S. Health Policy Update: Medicaid Work Rules, Medicare Changes, and ACA Uncertainty
Comprehensive update on U.S. health policy covering Medicaid work exemptions, Medicare Advantage financial reforms, ACA subsidy debates, and public health regulatory shifts impacting insurers and providers.
2025 Payer + Provider Summit Highlights AI, Value-Based Care, and Community Partnerships
Insights from the 2025 Payer + Provider Summit on AI-driven care, value-based models, community partnerships, and the need for stable federal policies to advance primary and preventive care.
HRAs Gain Momentum as U.S. Health Care Alternatives Post-Obamacare
Explore the role of Health Reimbursement Arrangements (HRAs) as a growing alternative to Obamacare in the U.S. health insurance market, especially after recent government funding developments.